Clinical Trial Update: Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Januse kinase inhibition with filgotinib to silence autoreactive B cells in rheumatoid arthritis is ongoing, status currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Filgotinib (filgotinib)

Snippet

Sponsor: Leiden University Medical Center | Conditions: Rheumatoid Arthritis | Phase 4 | Status: UNKNOWN